TIMELINE: T-BOOSTER

T-BOOSTER: BILLION DOLLAR MARKET

Global Market

The global market is valued at $86 billion in 2024 and is projected to grow $132 billion by 2028 reflecting a CAGR of about 11.38%. Our initial market capture strategy for 2025–2026 focuses on key regions, including the UK, EU, USA, and Bangladesh, where the demand for immune health products is robust.

By targeting these markets, we aim to capture an estimated $48 million share—just 0.3% of the global market. This conservative outlook underscores the significant growth potential for T-Booster as we continue to expand and establish a strong presence in the competitive immune supplement industry.

Our Consumers
  • Seniors: Seeking rejuvenated immunity

  • Wellness Warriors: Active supplement consumers

  • Medical Advocates: Professionals endorsing supplements

  • Biohackers: On a quest for age-defiance and optimal health

Our Partners

Manufacturing:

  • G&G Vitamins: Trusted manufacturer for our T-BOOSTER supplement.

Clinical Research:

  • BSMMU, Bangladesh: Conducting comprehensive clinical trials.

Retail Distribution:

  • Tesco & Holland & Barrett, UK: Leading high street retailers.

  • Amazon: Global online distribution.

  • Mango TX, USA: Expanding reach in the American market.

Retail:

  • T-BOOSTER in supermarkets

E-commerce Dominance:

  • Amazon and top wellness sites

Practitioner's Choice:

  • Establishing trust via pharmacies, clinics, and doctor recommendations

Specialty Health Stores:

  • Physical spaces in niche health stores, closer to the consumer.

Direct-to-Doorstep:

  • Via our official site, even offering subscription models for convenience.

T-BOOSTER Market Entry Strategy

Here's the game-changer for investors:

  • A one-of-its-kind formula, backed by concrete science

  • Solid IP protection including patents, safeguarding our unique offering

  • The first and only supplement boasting the reversal of thymic involution

  • Crafted under the guidance of drug discovery maestros

  • A faster market entry route, sidestepping pharmaceutical red tape

  • Targeting a whopping 700 million potential users

  • Highly scalable, digital-first sales approach

  • Building walls so high, competitors would need a ladder

  • Ensuring T-BOOSTER becomes synonymous with immune health

T-BOOSTER: What Sets Us Apart?
  • Initially targeting the UK, EU, USA and Bangladesh

  • Market of over 1 billion people.

  • Annual spend on immune supplements in these regions: Over $15 billion

Target Market Focus